Skip to main content
Trovagene reports positive results for PCM-075 in early testing
2/13/2018

Trovagene presented positive early-stage trial results at a recent symposium on PCM-075, an experimental prostate cancer drug for use with Johnson & Johnson's Zytiga, or abiraterone acetate.

Full Story: